Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SYRE compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name
SYRE
Spyre Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
TNGX
Tango Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SYRE
Spyre Therapeutics, Inc.
vs
TNGX
Tango Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
SYRE
Spyre Therapeutics, Inc.
Change
99.08
▲
+3.74%
· post 95.01
· delayed
Mkt cap
$8.4B
Revenue
—
Revenue
—
TNGX
Tango Therapeutics, Inc.
Change
23.24
▲
+6.79%
· post 23.24
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$3.7B
Revenue
$54M
Q3 FY25
Revenue
$42M
FY24
vs
Compare
After hours
Nov 3 '26
delayed
SYRE
Spyre Therapeutics, Inc.
vs
TNGX
Tango Therapeutics, Inc.
99.08
▲
+3.74%
post 95.01
delayed
Price
23.24
▲
+6.79%
post 23.24
delayed
$8.4B
Mkt cap
$3.7B
—
Revenue
$54M
Q3 FY25
—
Revenue
$42M
FY24
Change
Change
SYRE
99.08
▲
+3.74%
vs
TNGX
23.24
▲
+6.79%
After hours
Nov 3 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SYRE, solid
TNGX, dashed